Tumor necrosis factor activation of vagal afferent terminal calcium is blocked by cannabinoids

Journal of Neuroscience

Volumn 32, Issue 15, 2012, Pages 5237-5241

  Rogers, Richard C ^a   Hermann, Gerlinda E ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CANNABINOID RECEPTOR AGONIST; CYCLIC AMP DEPENDENT PROTEIN KINASE; N [2 (4 BROMOCINNAMYLAMINO) ETHYL] 5 ISOQUINOLINESULFONAMIDE; RYANODINE RECEPTOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; ELECTROSTIMULATION; FEMALE; MALAISE; MALE; NERVE POTENTIAL; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SOLITARY TRACT NUCLEUS; TIME LAPSE IMAGING; VAGUS NERVE;

ANIMALS; BRAIN STEM; CALCIUM; CANNABINOIDS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DIFFUSION CHAMBERS, CULTURE; ELECTRIC STIMULATION; FEMALE; IMAGE PROCESSING, COMPUTER-ASSISTED; ISOQUINOLINES; MALE; MICROSCOPY, CONFOCAL; NEURONS, AFFERENT; PRESYNAPTIC TERMINALS; PROTEIN KINASE INHIBITORS; RATS; RATS, LONG-EVANS; RECEPTOR, CANNABINOID, CB1; SOLITARY NUCLEUS; SULFONAMIDES; TUMOR NECROSIS FACTOR-ALPHA; VAGUS NERVE;

EID: 84859527962     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.6220-11.2012     Document Type: Article

References (52)

1. Andresen MC, Yang M (1995) Dynamics of sensory afferent synaptic transmission in aortic baroreceptor regions on nucleus tractus solitarius. J Neurophysiol 74:1518-1528.
2. Austgen JR, Hermann GE, Dantzler HA, Rogers RC, Kline DD (2011) Hydrogen sulfide augments synaptic neurotransmission in the nucleus of the solitary tract. J Neurophysiol 106:1822-1832.
3. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M (2008) Growth factors and cytokines in wound healing. Wound Repair Regen 16:585-601.
4. Bashir MM, Sharma MR, Werth VP (2009) TNF-alpha production in the skin. Arch Dermatol Res 301:87-91.
5. Ben Amar M. (2006) Cannabinoids in medicine: A review of their therapeutic potential. J Ethnopharmacol 105:1-25.
6. Blessing WW (1997) Eating and metabolism. In: The lower brainstem and bodily homeostasis, pp 323-372. Oxford: Oxford UP.
7. Collin T, Marty A, Llano I (2005) Presynaptic calcium stores and synaptic transmission. Curr Opin Neurobiol 15:275-281.
8. Davis M, Maida V, Daeninck P, Pergolizzi J (2007) The emerging role of cannabinoid neuromodulators in symptom management. Support Care Cancer 15:63-71.
9. Derbenev AV, Stuart TC, Smith BN (2004) Cannabinoids suppress synaptic input to neurones of the rat dorsal motor nucleus of the vagus nerve. J Physiol 559:923-938.
10. Deshpande DA, Walseth TF, Panettieri RA, Kannan MS (2003) CD38/cyclic ADP-ribose-mediated Ca2+ signaling contributes to airway smooth muscle hyper-responsiveness. FASEB J 17:452-454.
11. Emch GS, Hermann GE, Rogers RC (2000) TNF-alpha activates solitary nucleus neurons responsive to gastric distension. Am J Physiol Gastrointest Liver Physiol 279:G582-G586.
12. Gorter RW (1999) Cancer cachexia and cannabinoids. Forsch Komplementarmed 6 [Suppl 3]:21-22.
13. Green EC (1935) Anatomy of the rat. New York: Hafner Publishing
14. Hall W, Christie M, Currow D (2005) Cannabinoids and cancer: causation, remediation, and palliation. Lancet Oncol 6:35-42.
15. Hara K, Harris RA (2002) The anesthetic mechanism of urethane: the effects on neurotransmitter-gated ion channels. Anesth Analg 94:313-318, table of contents.
16. Hedayat M, Mahmoudi MJ, Rose NR, Rezaei N (2010) Proinflammatory cytokines in heart failure: double-edged swords. Heart Fail Rev 15:543-562.
17. Helmchen F (2000) Calibration of fluorescent calcium indicators. In: Imaging neurons: a laboratory manual (Yuste R, Lanni F, Konnerth A, eds), pp 32.31-32.39. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
18. Hermann GE, Rogers RC (2008) TNFalpha: a trigger of autonomic dysfunction. Neuroscientist 14:53-67.
19. Hermann GE, Rogers RC (2009) TNF activates astrocytes and catecholaminergic neurons in the solitary nucleus: implications for autonomic control. Brain Res 1273:72-82.
20. Hermann GE, Tovar CA, Rogers RC (2002) LPS-induced suppression of gastric motility relieved by TNFR:Fc construct in dorsal vagal complex. Am J Physiol Gastrointest Liver Physiol 283:G634-G639.
21. Hermann GE, Holmes GM, Rogers RC (2005) TNF(alpha) modulation of visceral and spinal sensory processing. Curr Pharm Des 11:1391-1409.
22. Hoddah H, Marcantoni A, Comunanza V, Carabelli V, Carbone E (2009) L-type channel inhibition by CB1 cannabinoid receptors is mediated by PTX-sensitive G proteins and cAMP/PKA in GT1-7 hypothalamic neurons. Cell Calcium 46:303-312.
23. Huang CC, Lo SW, Hsu KS (2001) Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons. J Physiol 532:731-748.
24. Kalant H (2001) Medicinal use of cannabis: history and current status. Pain Res Manag 6:80-91.
25. Katchman AN, Hershkowitz N (1993) Early anoxia-induced vesicular glutamate release results from mobilization of calcium from intracellular stores. J Neurophysiol 70:1-7.
26. Katz B, Miledi R (1967) A study of synaptic transmission in the absence of nerve impulses. J Physiol 192:407-436.
27. Kline DD, Hendricks G, Hermann G, Rogers RC, Kunze DL (2009) Dopamine inhibits N-type channels in visceral afferents to reduce synaptic transmitter release under normoxic and chronic intermittent hypoxic conditions. J Neurophysiol 101:2270-2278.
28. Lanner JT, Georgiou DK, Joshi AD, Hamilton SL (2010) Ryanodine receptors: structure, expression, molecular details, and function in calcium release. Cold Spring Harb Perspect Biol 2:a003996.
29. Lelli A, Perin P, Martini M, Ciubotaru CD, Prigioni I, Valli P, Rossi ML, Mammano F (2003) Presynaptic calcium stores modulate afferent release in vestibular hair cells. J Neurosci 23:6894-6903.
30. Liu YL, Zhou LJ, Hu NW, Xu JT, Wu CY, Zhang T, Li YY, Liu XG (2007) Tumor necrosis factor-alpha induces long-term potentiation of C-fiber evoked field potentials in spinal dorsal horn in rats with nerve injury: the role of NF-kappa B, JNK and p38 MAPK. Neuropharmacology 52:708-715.
31. Machado Rocha FC, Stéfano SC, De Cássia Haiek R, Rosa Oliveira LM, Da Silveira DX (2008) Therapeutic use of Cannabis sativa on chemotherapyinduced nausea and vomiting among cancer patients: systematic review and meta-analysis. Eur J Cancer Care (Engl) 17:431-443.
32. Maenhaut N, Van de Voorde J (2011) Regulation of vascular tone by adipocytes. BMC Med 9:25.
33. McDougal DH, Hermann GE, Rogers RC (2011) Vagal afferent stimulation activates astrocytes in the nucleus of the solitary tract viaAMPAreceptors: evidence of an atypical neural-glial interaction in the brainstem. J Neurosci 31:14037-14045.
34. McDougall SJ, Peters JH, Andresen MC (2009) Convergence of cranial visceral afferents within the solitary tract nucleus. J Neurosci 29:12886-12895.
35. Pan W, Zadina JE, Harlan RE, Weber JT, Banks WA, Kastin AJ (1997) Tumor necrosis factor-alpha: a neuromodulator in the CNS. Neurosci Biobehav Rev 21:603-613.
36. Park KM, Bowers WJ (2010) Tumor necrosis factor-alpha mediated signaling in neuronal homeostasis and dysfunction. Cell Signal 22:977-983.
37. Parker LA, Rock EM, Limebeer CL (2011) Regulation of nausea and vomiting by cannabinoids. Br J Pharmacol 163:1411-1422.
38. Pickering M, Cumiskey D, O'Connor JJ (2005) Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system. Exp Physiol 90:663-670.
39. Pogrebniak HW, Matthews W, Pass HI (1991) Chemotherapy amplifies production of tumor necrosis factor. Surgery 110:231-237.
40. Pollock J, McFarlane SM, Connell MC, Zehavi U, Vandenabeele P, MacEwan DJ, Scott RH (2002) TNF-alpha receptors simultaneously activate Ca2+mobilisation and stress kinases in cultured sensory neurones. Neuropharmacology 42:93-106.
41. Rogers RC, Hermann GE (2008) Mechanisms of action of CCK to activate central vagal afferent terminals. Peptides 29:1716-1725.
42. Rogers RC, Hermann GE (2012) Brainstem control of gastric function. In: Physiology of the gastrointestinal tract, Ed 4 (Johnson LR, ed), pp 861-892. Burlington, MA: Elsevier Academic.
43. Rogers RC, McTigue DM, Hermann GE (1995) Vagovagal reflex control of digestion: afferent modulation by neural and "endoneurocrine" factors. Am J Physiol 268:G1-G10.
44. Rogers RC, Nasse JS, Hermann GE (2006a) Live-cell imaging methods for the study of vagal afferents within the nucleus of the solitary tract. J Neurosci Methods 150:47-58.
45. Rogers RC, Van Meter MJ, Hermann GE (2006b) Tumor necrosis factor potentiates central vagal afferent signaling by modulating ryanodine channels. J Neurosci 26:12642-12646.
46. Slatkin NE (2007) Cannabinoids in the treatment of chemotherapyinduced nausea and vomiting: beyond prevention of acute emesis. J Support Oncol 5 [Suppl 3]:1-9.
47. Stellwagen D, Beattie EC, Seo JY, Malenka RC (2005) Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J Neurosci 25:3219-3228.
48. Syed AA, Rattansingh A, Furtado SD (2005) Current perspectives on the management of gastroparesis. J Postgrad Med 51:54-60.
49. Thaler A, Gupta A, Cohen SP (2011) Cannabinoids for pain management. Adv Psychosom Med 30:125-138.
50. Walker JM, Hohmann AG (2005) Cannabinoid mechanisms of pain suppression. Handb Exp Pharmacol 168:509-554.
51. Youn DH, Wang H, Jeong SJ (2008) Exogenous tumor necrosis factor-alpha rapidly alters synaptic and sensory transmission in the adult rat spinal cord dorsal horn. J Neurosci Res 86:2867-2875.
52. Zhuang SY, Bridges D, Grigorenko E, McCloud S, Boon A, Hampson RE, Deadwyler SA (2005) Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores. Neuropharmacology 48:1086-1096.